Cover image for Vol. 11 Issue 23

Editorial Board Chairs: Antonello Mai, Rainer Metternich. Assoc. Editors: David Peralta, Scott Williams (Sr)

Impact Factor: 2.98

ISI Journal Citation Reports © Ranking: 2015: 18/59 (Chemistry Medicinal); 77/255 (Pharmacology & Pharmacy)

Online ISSN: 1860-7187

Associated Title(s): Angewandte Chemie International Edition, Chemistry - A European Journal, Chemistry – An Asian Journal, ChemBioChem, Medicinal Research Reviews, Molecular Informatics

Recently Published Issues

See all

Latest News

Browse more news

November 23, 2016

13th WCMBC in Steamboat Springs: January 2017

13th WCMBC in Steamboat Springs: January 2017ChemMedChem will be sponsoring the next Winter Conference on Medicinal & Bioorganic Chemistry this coming January 22nd–26th in Steamboat Springs, Colorado. The organizers have lined up another impressive list of presenters for this year's event. And as if excellent cutting-edge science weren't enough, this meeting comes with a healthy dose of play time too: unforgettable skiing in the bright sun and deep snow of northern Colorado. Make sure to register soon!

Your Comment...

[Browse more news]

Recently Published Articles

  1. Cytotoxicity of a series of norcantharidin inspired tetrahydroepoxyisoindole carboxamides

    Christopher Peter Gordon, Lawson K Spare, Pasquale Falsetta, Jayne Gilbert, David G Harman, Mark A Baker, Feng Li, Adam McCluskey, Jack K Clegg, Jennette A Sakoff and Janice R Aldrich-Wright

    Accepted manuscript online: 6 DEC 2016 12:20AM EST | DOI: 10.1002/cmdc.201600573

  2. Design, Synthesis, and Evaluation of Dasatinib–Amino Acid and Dasatinib–Fatty Acid Conjugates as Protein Tyrosine Kinase Inhibitors

    Prof. Rakesh K. Tiwari, Dr. Alex Brown, Dr. Neda Sadeghiani, Dr. Amir Nasrolahi Shirazi, Jared Bolton, Amanda Tse, Prof. Gennady Verkhivker, Prof. Keykavous Parang and Prof. Gongqin Sun

    Version of Record online: 5 DEC 2016 | DOI: 10.1002/cmdc.201600387

    Thumbnail image of graphical abstract

    Conjugated for specificity: 25 derivatives of dasatinib were synthesized by esterification with fatty acids and amino acids to improve the specificity for Src, Csk, and Abl kinases. We reasoned that by extending dasatinib from the ATP binding pocket into variable regions, the resulting derivatives may undergo new kinase-specific interactions, which would lead to greater inhibitory specificity toward a given kinase.

  3. Discovery of a Novel Scaffold as an Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Based on the Pyrrolopiperazinone Alkaloid, Longamide B

    Zenyu Shiokawa, Emi Kashiwabara, Daisuke Yoshidome, Prof. Dr. Koichi Fukase, Dr. Shinsuke Inuki and Prof. Dr. Yukari Fujimoto

    Version of Record online: 5 DEC 2016 | DOI: 10.1002/cmdc.201600446

    Thumbnail image of graphical abstract

    A new scaffold: The pyrrolopiperazinone alkaloid longamide B and its derivatives were identified as novel IDO1 inhibitors based on docking studies and small library synthesis. The thioamide derivative showed higher IDO1 inhibitory activity than longamide B and displayed activity similar to that of a representative IDO1 inhibitor, 1-methyl-tryptophan. These results suggest that the pyrrolopiperazinone scaffold of longamide B could be used for IDO1 inhibitors.

  4. A Quinacrine Analogue Selective Against Gastric Cancer Cells: Insight from Biochemical and Biophysical Studies

    Ana Gomes, Dr. Iva Fernandes, Dr. Cátia Teixeira, Prof. Nuno Mateus, Prof. M. J. Sottomayor and Prof. Paula Gomes

    Version of Record online: 5 DEC 2016 | DOI: 10.1002/cmdc.201600477

    Thumbnail image of graphical abstract

    The core of the matter: A quinacrine analogue, formerly developed as a dual-stage antimalarial, seems to be a valuable template for additional structural optimization toward specific agents against gastric cancer. Nuclear targeting of this compound and its interactions with calf thymus DNA were assessed, and the evidence suggests that this compound has the ability to reach the nucleus and to interact with DNA.

  5. Design, synthesis, and evaluation of 2,9-bis[(substituted-aminomethyl)phenyl]-1,10-phenanthroline derivatives as G-quadruplex ligands

    Nassima Meriem Gueddouda, Miyanou Rosales Hurtado, Stéphane Moreau, Luisa Ronga, Rabindra Nath Das, Solène Savrimoutou, Sandra Rubio, Adrien Marchand, Oscar Mendoza, Mathieu Marchivie, Lilian Elmi, Albain Chansavang, Vanessa Desplat, Valérie Gabelica, Anne Bourdoncle, Jean-Louis Mergny and Jean Guillon

    Accepted manuscript online: 4 DEC 2016 10:18PM EST | DOI: 10.1002/cmdc.201600511